c-erbB-2 oncoprotein over-expression in breast cancer and its relationship to histology and grade in a Ugandan population

East Afr Med J. 2006 Aug;83(8):411-5. doi: 10.4314/eamj.v83i8.9454.

Abstract

Objective: To evaluate c-erbB-2 oncoprotein over expression in breast cancer patients of Kyadondo county and also relate this oncoprotein to histological type and grade of the tumour.

Design: Cross-sectional study.

Setting: Pathology Department, Faculty of Medicine, Makerere University.

Subjects: Seventy two breast cancer patients who were among the 174 entered in survival study had their paraffin breast tissue blocks retrieved from archives of Pathology Department and had their c-erbB-2 determined by peroxidase-labeled streptavidin-biotin immunohistochemical method.

Results: c-erbB-2 oncoprotein was over expressed in 33.3% of the tumours and correlated positively with histological grade (p = 0.007). TH oncoprotein over expression was not restricted to any particular histological type and there was no association with age of patient.

Conclusion: The over expression of c-erbB-2 oncoprotein observed in one third of breast cancer patients of this African population could partly explain the observed poor survival rate reported in this community.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Cross-Sectional Studies
  • DNA, Neoplasm / genetics
  • DNA, Neoplasm / immunology
  • Female
  • Gene Expression Regulation, Neoplastic / immunology
  • Genes, erbB-2 / genetics
  • Genes, erbB-2 / immunology
  • Genes, erbB-2 / physiology*
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Receptor, ErbB-2 / genetics
  • Receptor, ErbB-2 / metabolism*
  • Survival Rate
  • Uganda / epidemiology

Substances

  • Biomarkers, Tumor
  • DNA, Neoplasm
  • Receptor, ErbB-2